HC Wainwright & Co. Reiterates Buy on Compugen, Maintains $4 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on Compugen (NASDAQ: CGEN) and maintained a price target of $4 for the stock.